$0.54
−1.57%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.56
From 52W high−99.63%
Volume63577.00
Market cap$1.97M
P/E (TTM)—
P/S (TTM)0.2x
Div yield—
Key dataOct 19, 2026
Open
$0.56
From 52W high
−99.63%
Volume
63577.00
Market cap
$1.97M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.2x
P/E (TTM)
—
RSI (14)
31.2
MomentumView details →
1D Return
−1.57%
YTD Return
−99.08%
SummaryUpdated Jun 1, 2026
Nuwellis, Inc. (NASDAQ:NUWE) is a medical device company founded in 1999 and headquartered in Eden Prairie, Minnesota. Originally known as CHF Solutions, Inc., the company changed its name to Nuwellis in April 2021. The company specializes in developing, manufacturing, and commercializing medical devices for ultrafiltration therapy, primarily targeting patients with fluid overload conditions who have not responded adequately to traditional diuretic medications. With over two decades of experience in the field, Nuwellis has established itself as a focused player in the specialized medical device market, serving hospitals and clinics both domestically and internationally through direct sales and distributor partnerships.
Similar companies
Latest newsMore news →
Nuwellis announced that it will convene a Medical & Nursing Advisory Board on November 18–19, 2026, to support development of its Vivian pediatric CRRT platform.12d agoNuwellis, Inc. announced its participation in four leading medical conferences in October 2026, where it will highlight its Aquadex SmartFlow system for fluid management in pediatric care, critical care, and heart failure.19d agoNuwellis reported that 31 Aquadex SmartFlow consoles were sold year-to-date, exceeding full-year console sales in seven of the past 10 years.33d ago